Requlred Information [The following information applles to the questions displayed below.] The December 31, 2024, unadjusted trial balance for the WolksteIn Drug Company is presented below. December 31 is the company's year-end reporting date. The following year-end adjusting entries are required: a. Depreclation expense for the year on the equipment is $11,400. b. Salarles at year-end should be accrued in the amount of $6,320. Required: 1. Prepare and complete a worksheet